|||
200余种肿瘤学期刊的影响因子
诸平
2019年6月20日公布的《期刊引证报告》(Journal Citation Reports,JCR),对其其中百余种医学期刊的影响因子已经进行了介绍(百余种医学期刊影响因子(IF2018)),下面介绍200余种肿瘤科学(Oncology)期刊,这些期刊的影响因子从不足0.02到超过115.8,供大家参考。如果有读者发现问题请及时指出,以便尽快修改.
Medical Journals (Oncology) Impact Factors 2019
Rank | Title | Impact Factor |
---|---|---|
1 | CA-CANCER J CLIN | 115.84 |
2 | NAT REV CANCER | 37.4 |
3 | LANCET ONCOL | 24.69 |
4 | CANCER CELL | 23.523 |
5 | CANCER DISCOV | 19.453 |
6 | J CLIN ONCOL | 18.428 |
7 | NAT REV CLIN ONCOL | 14.18 |
8 | JNCI-J NATL CANCER I | 12.583 |
9 | LEUKEMIA | 10.431 |
10 | SEMIN CANCER BIOL | 9.33 |
11 | CANCER RES | 9.329 |
12 | CLIN CANCER RES | 8.722 |
13 | ONCOGENE | 8.459 |
14 | BBA-REV CANCER | 7.845 |
15 | CANCER TREAT REV | 7.588 |
16 | J PATHOL | 7.429 |
17 | CANCER METAST REV | 7.234 |
18 | ANN ONCOL | 7.04 |
19 | STEM CELLS | 6.523 |
20 | ONCOTARGET | 6.359 |
21 | ONCOIMMUNOLOGY | 6.266 |
22 | MOL CANCER THER | 5.683 |
23 | CANCER LETT | 5.621 |
24 | NEURO-ONCOLOGY | 5.562 |
25 | BREAST CANCER RES | 5.49 |
26 | EUR J CANCER | 5.417 |
27 | CARCINOGENESIS | 5.334 |
28 | MOL ONCOL | 5.331 |
29 | ADV CANCER RES | 5.321 |
30 | J THORAC ONCOL | 5.282 |
31 | INT J CANCER | 5.085 |
32 | CANCER-AM CANCER SOC | 4.889 |
33 | ONCOLOGIST | 4.865 |
34 | BRIT J CANCER | 4.836 |
35 | J HEMATOL ONCOL | 4.812 |
36 | MOL CARCINOGEN | 4.808 |
37 | ENDOCR-RELAT CANCER | 4.805 |
38 | PIGM CELL MELANOMA R | 4.619 |
39 | CLIN EPIGENETICS | 4.543 |
40 | J MAMMARY GLAND BIOL | 4.526 |
41 | CURR OPIN ONCOL | 4.466 |
42 | CANCER PREV RES | 4.444 |
43 | J EXP CLIN CANC RES | 4.429 |
44 | MOL CANCER RES | 4.38 |
45 | RADIOTHER ONCOL | 4.363 |
46 | RECENT PAT ANTI-CANC | 4.295 |
47 | INT J RADIAT ONCOL | 4.258 |
48 | MOL CANCER | 4.257 |
49 | NEOPLASIA | 4.252 |
50 | CANCER J | 4.237 |
51 | J NATL COMPR CANC NE | 4.178 |
52 | AM J CANCER RES | 4.165 |
53 | CANCER EPIDEM BIOMAR | 4.125 |
54 | GENE CHROMOSOME CANC | 4.041 |
55 | SEMIN RADIAT ONCOL | 4.029 |
56 | CRIT REV ONCOL HEMAT | 4.027 |
57 | J IMMUNOTHER | 4.008 |
58 | TARGET ONCOL | 4 |
59 | LUNG CANCER | 3.958 |
60 | ONCOGENESIS | 3.952 |
61 | CANCER IMMUNOL IMMUN | 3.941 |
62 | BREAST CANCER RES TR | 3.94 |
63 | ANN SURG ONCOL | 3.93 |
64 | SEMIN ONCOL | 3.898 |
65 | CANCER IMMUNOL RES | 3.857 |
66 | GYNECOL ONCOL | 3.774 |
67 | GASTRIC CANCER | 3.719 |
68 | TUMOR BIOL | 3.611 |
69 | ORAL ONCOL | 3.607 |
70 | BONE MARROW TRANSPL | 3.57 |
71 | J ENVIRON SCI HEAL C | 3.56 |
72 | CANCER SCI | 3.523 |
73 | CURR CANCER DRUG TAR | 3.522 |
74 | CANCER CONTROL | 3.5 |
75 | CLIN EXP METASTAS | 3.491 |
76 | BLOOD CANCER J | 3.467 |
77 | PROSTATE CANCER P D | 3.425 |
78 | AM J TRANSL RES | 3.402 |
79 | CLIN ONCOL-UK | 3.398 |
80 | BMC CANCER | 3.362 |
81 | CANCER CYTOPATHOL | 3.354 |
82 | CANCER RES TREAT | 3.318 |
83 | J CANCER SURVIV | 3.303 |
84 | J CANCER | 3.271 |
85 | SURG ONCOL | 3.27 |
86 | EXP CELL RES | 3.246 |
87 | J SURG ONCOL | 3.244 |
88 | CLIN LUNG CANCER | 3.104 |
89 | HEMATOL ONCOL | 3.084 |
90 | J CANCER RES CLIN | 3.081 |
91 | CANCER BIOL THER | 3.072 |
92 | J NEURO-ONCOL | 3.07 |
93 | AM J CLIN ONCOL-CANC | 3.062 |
94 | CELL ONCOL | 3.032 |
95 | EUR J CANCER PREV | 3.031 |
96 | INT J ONCOL | 3.025 |
97 | EJSO-EUR J SURG ONC | 3.009 |
98 | ACTA ONCOL | 2.997 |
99 | BIODRUGS | 2.989 |
100 | CANCER GENET-NY | 2.975 |
101 | INVEST NEW DRUG | 2.919 |
102 | STRAHLENTHER ONKOL | 2.914 |
103 | CURR ONCOL REP | 2.891 |
104 | LEUKEMIA LYMPHOMA | 2.891 |
105 | TRANSL ONCOL | 2.884 |
106 | THER ADV MED ONCOL | 2.827 |
107 | CURR TREAT OPTION ON | 2.822 |
108 | CLIN COLORECTAL CANC | 2.813 |
109 | ONCOL NURS FORUM | 2.788 |
110 | CANCER CHEMOTH PHARM | 2.769 |
111 | UROL ONCOL-SEMIN ORI | 2.768 |
112 | CANCER CELL INT | 2.766 |
113 | BRACHYTHERAPY | 2.758 |
114 | CANCER CAUSE CONTROL | 2.735 |
115 | CANCER EPIDEMIOL | 2.711 |
116 | CANCER GENOM PROTEOM | 2.7 |
117 | INT J HYPERTHER | 2.645 |
118 | MED ONCOL | 2.634 |
119 | RADIAT ONCOL | 2.546 |
120 | ASIAN PAC J CANCER P | 2.514 |
121 | CANCER MED-US | 2.5 |
122 | J GYNECOL ONCOL | 2.494 |
123 | FUTURE ONCOL | 2.477 |
124 | ANTI-CANCER AGENT ME | 2.469 |
125 | PSYCHO-ONCOLOGY | 2.443 |
126 | ONCOLOGY-BASEL | 2.422 |
127 | CANCER GENE THER | 2.416 |
128 | PEDIATR BLOOD CANCER | 2.386 |
129 | BREAST | 2.381 |
130 | SUPPORT CARE CANCER | 2.364 |
131 | INTEGR CANCER THER | 2.361 |
132 | INFECT AGENTS CANCER | 2.358 |
133 | LEUKEMIA RES | 2.351 |
134 | CLIN GENITOURIN CANC | 2.322 |
135 | NUTR CANCER | 2.322 |
136 | ONCOLOGY-NY | 2.322 |
137 | ONCOTARGETS THER | 2.311 |
138 | ONCOL REP | 2.301 |
139 | HEMATOL ONCOL CLIN N | 2.295 |
140 | MELANOMA RES | 2.282 |
141 | EXPERT REV ANTICANC | 2.249 |
142 | CANCER INVEST | 2.218 |
143 | CURR HEMATOL MALIG R | 2.2 |
144 | CHIN J CANCER | 2.155 |
145 | INT J CLIN ONCOL | 2.128 |
146 | CLIN BREAST CANCER | 2.107 |
147 | CLIN TRANSL ONCOL | 2.077 |
148 | CANCER IMAGING | 2.066 |
149 | CL LYMPH MYELOM LEUK | 2.02 |
150 | JPN J CLIN ONCOL | 2.016 |
151 | PHOTODIAGN PHOTODYN | 2.014 |
152 | FAM CANCER | 1.977 |
153 | CANCER NURS | 1.966 |
154 | INT J GYNECOL CANCER | 1.958 |
155 | CHINESE J CANCER RES | 1.935 |
156 | RADIOL ONCOL | 1.912 |
157 | INT J CLIN EXP PATHO | 1.891 |
158 | NEOPLASMA | 1.865 |
159 | J GERIATR ONCOL | 1.859 |
160 | PATHOL ONCOL RES | 1.855 |
161 | ANTICANCER RES | 1.826 |
162 | SURG ONCOL CLIN N AM | 1.806 |
163 | CURR ONCOL | 1.785 |
164 | ANTI-CANCER DRUG | 1.784 |
165 | CANCER BIOTHER RADIO | 1.778 |
166 | TECHNOL CANCER RES T | 1.73 |
167 | CANCER BIOMARK | 1.721 |
168 | J CHEMOTHERAPY | 1.604 |
169 | BREAST CANCER-TOKYO | 1.585 |
170 | J BREAST CANCER | 1.576 |
171 | EUR J CANCER CARE | 1.564 |
172 | MOL MED REP | 1.554 |
173 | ONCOL LETT | 1.554 |
174 | ASIA-PAC J CLIN ONCO | 1.542 |
175 | HERED CANCER CLIN PR | 1.472 |
176 | EUR J ONCOL NURS | 1.426 |
177 | BREAST J | 1.411 |
178 | CANCER RADIOTHER | 1.411 |
179 | WORLD J SURG ONCOL | 1.408 |
180 | INT J BIOL MARKER | 1.371 |
181 | CHEMOTHERAPY | 1.288 |
182 | J CONTEMP BRACHYTHER | 1.284 |
183 | TUMORI | 1.269 |
184 | J CANCER EDUC | 1.23 |
185 | BRAIN TUMOR PATHOL | 1.224 |
186 | J BONE ONCOL | 1.205 |
187 | PEDIATR HEMAT ONCOL | 1.096 |
188 | ONCOL RES | 1.059 |
189 | FOLIA BIOL-PRAGUE | 1 |
190 | CLIN J ONCOL NURS | 0.91 |
191 | J PEDIATR ONCOL NURS | 0.903 |
192 | J PEDIAT HEMATOL ONC | 0.902 |
193 | THORAC CANCER | 0.898 |
194 | ONKOLOGIE | 0.863 |
195 | ANAL CELL PATHOL | 0.846 |
196 | INDIAN J CANCER | 0.802 |
197 | J CANCER RES THER | 0.791 |
198 | BIRTH DEFECTS RES B | 0.768 |
199 | MED DOSIM | 0.76 |
200 | J BUON | 0.741 |
201 | BREAST CARE | 0.627 |
202 | EUR J GYNAECOL ONCOL | 0.611 |
203 | B CANCER | 0.604 |
204 | CURR PROB CANCER | 0.526 |
205 | UHOD-ULUSLAR HEMATOL | 0.282 |
206 | ONKOLOGE | 0.136 |
207 | PSYCHO-ONCOLOGIE | 0.134 |
208 | ONCOLOGIE | 0.057 |
209 | HORM CANCER-US | 0.019 |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-11-24 07:06
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社